Synthetic biologists from Yale were able to re-write the genetic code of an organism — a novel genomically recoded organism ...

Learn more about whether Halozyme Therapeutics, Inc. or Twist Bioscience Corporation is a better investment based on AAII's ...

Learn more about whether Protagonist Therapeutics, Inc. or Twist Bioscience Corporation is a better investment based on ...

A temporally resolved CRISPR-Cas9 screen reveals DAC-induced DNA damage drives trans-cell cycle cytotoxicity that depends on ...

Protein synthesis is vital for life, translating genetic information from DNA to functional proteins through transcription ...

We recently compiled a list of the Cathie Wood’s Stock Portfolio: 2025 Stock Picks. In this article, we are going to take a ...

His research explores the rise of generative AI and accelerated use of AI more broadly to advance drug and scientific discovery. Reuben leads Gartner's coverage of genomics, multiomics, cell and gene ...

A new drug delivery system shows promise for treating a rare, aggressive form of cancer affecting pregnant women and new mothers, and it has potential with other cancers as well.

This engineered genome will help experts tailor organisms to fit the needs of their ever-changing environments.